257 related articles for article (PubMed ID: 18157795)
41. Is Cisterna Magna Width a Useful First-Trimester Marker of Aneuploidy?
Pauta M; Grande M; Borobio V; Illanes C; Soler A; Nogué L; Borrell A
Fetal Diagn Ther; 2020; 47(6):457-463. PubMed ID: 31694020
[TBL] [Abstract][Full Text] [Related]
42. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
[TBL] [Abstract][Full Text] [Related]
43. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan.
Faiola S; Tsoi E; Huggon IC; Allan LD; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Jul; 26(1):22-7. PubMed ID: 15937972
[TBL] [Abstract][Full Text] [Related]
44. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects.
Cicero S; Longo D; Rembouskos G; Sacchini C; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Jul; 22(1):31-5. PubMed ID: 12858299
[TBL] [Abstract][Full Text] [Related]
45. Three-dimensional evaluation of mid-facial hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks of gestation.
Dagklis T; Borenstein M; Peralta CF; Faro C; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Sep; 28(3):261-5. PubMed ID: 16865677
[TBL] [Abstract][Full Text] [Related]
46. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
[TBL] [Abstract][Full Text] [Related]
47. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
[TBL] [Abstract][Full Text] [Related]
48. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
Becker R; Wegner RD
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
[TBL] [Abstract][Full Text] [Related]
49. Fetal echocardiography at the time of the nuchal translucency scan.
Lombardi CM; Bellotti M; Fesslova V; Cappellini A
Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
[TBL] [Abstract][Full Text] [Related]
50. Placental volume measured by three-dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects.
Wegrzyn P; Faro C; Falcon O; Peralta CF; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Jul; 26(1):28-32. PubMed ID: 15937964
[TBL] [Abstract][Full Text] [Related]
51. Association of aberrant right subclavian artery with abnormal karyotype and microarray results.
Svirsky R; Reches A; Brabbing-Goldstein D; Bar-Shira A; Yaron Y
Prenat Diagn; 2017 Aug; 37(8):808-811. PubMed ID: 28618053
[TBL] [Abstract][Full Text] [Related]
52. Predictive value of aberrant right subclavian artery for fetal chromosome aneuploidy in women of advanced maternal age.
Chen LP; Lai YF; Zhong XH; You JH; Chen JH; Xie JX; Chen XK; Chen XY; Lyu GR
BMC Pregnancy Childbirth; 2021 Feb; 21(1):148. PubMed ID: 33602166
[TBL] [Abstract][Full Text] [Related]
53. The mitral gap at 11 + 0 to 13 + 6 weeks: marker of trisomy 21 or artifact?
Maiz N; Dagklis T; Huggon I; Allan L; Nicolaides KH
Ultrasound Obstet Gynecol; 2007 Nov; 30(6):813-8. PubMed ID: 17924590
[TBL] [Abstract][Full Text] [Related]
54. Establishment and application of a normal range for nuchal translucency across the first trimester.
Scott F; Boogert A; Sinosich M; Anderson J
Prenat Diagn; 1996 Jul; 16(7):629-34. PubMed ID: 8843472
[TBL] [Abstract][Full Text] [Related]
55. Assessment of fetal anatomy at the 11-14-week ultrasound examination.
Souka AP; Pilalis A; Kavalakis Y; Kosmas Y; Antsaklis P; Antsaklis A
Ultrasound Obstet Gynecol; 2004 Dec; 24(7):730-4. PubMed ID: 15586371
[TBL] [Abstract][Full Text] [Related]
56. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
57. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
58. Single umbilical artery at 11-14 weeks' gestation: relation to chromosomal defects.
Rembouskos G; Cicero S; Longo D; Sacchini C; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Dec; 22(6):567-70. PubMed ID: 14689527
[TBL] [Abstract][Full Text] [Related]
59. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.
Maiz N; Plasencia W; Dagklis T; Faros E; Nicolaides K
Ultrasound Obstet Gynecol; 2008 Mar; 31(3):256-60. PubMed ID: 18307193
[TBL] [Abstract][Full Text] [Related]
60. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
